Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04576065 · ClinicalTrials.gov registry record · NA

Wake Forest Post-ICU Telehealth (WFIT) Program

A NA study of Critical Illness, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
413
Enrollment target
1
Study location

NCT04576065: Completed NA study of Critical Illness, sponsored by Wake Forest University Health Sciences.

NCT04576065 is a NA study of Critical Illness that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 413 participants, below the 3,134-participant average among 91 other Critical Illness trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04576065, a NA study of Critical Illness, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
413 participants
Enrollment target
1
Study location

Study Summary

Wake Forest Post-Intensive Care Unit Telehealth (WFIT) program consists of a nurse practitioner who has access to daily activity data as well as telehealth capabilities for 6 months post-hospital discharge in order to improve the post-critical illness care of patients. The study team expects that this program will reduce costs to patients. Through this intervention the study team hopes to improve quality of life, patient satisfaction, reduce readmissions and ER visits, and reduce mortality. The study team will perform a formal randomized controlled trial with a cost-effectiveness analysis to demonstrate its value.

Primary Outcome

Determine if the WFIT Program is cost-effective by measuring INB in the intervention arm (WFIT program) compared to an attention control arm. Incremental net benefit ($) = \[Change in Quality of Adjusted Life Year (QALY) \*100,000\] - \[Change in health care spending\] INB is defined as the difference between change in quality of life evaluated at monetary valuation of 1 QALY (currently $100,000) and change in health care spending. Using this measure, even if WFIT does not affect patient quali

Conditions Studied

Interventions

  • OTHER WFIT

Study Locations (1)

North Carolina

  • Wake Forest University Health Sciences - Winston-Salem

Trial Details

FieldValue
Enrollment Target 413 participants
Start Date 2021-03-19
Est. Completion 2023-09-14
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What the finished NCT04576065 record still lists

NCT04576065 is an interventional study that assigns participants to a tested intervention. The registered 413 participants enrollment target is mid-sized for trials with a published cap, below the 3,134-participant average among 91 other Critical Illness trials with a reported enrollment target (87% lower).

The record links to 1 condition, with Critical Illness appearing as the primary indexed condition, and to 1 intervention - of which WFIT is the first listed.

NCT04576065 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT04576065 about?

NCT04576065 is a clinical study titled "Wake Forest Post-ICU Telehealth (WFIT) Program". Wake Forest Post-Intensive Care Unit Telehealth (WFIT) program consists of a nurse practitioner who has access to daily activity data as well as telehealth capabilities for 6 months post-hospital discharge in order to improve the post-critical illness care of patients. The study team expects that th...

What is the current status of trial NCT04576065?

This trial is currently completed. It is a NA study. The enrollment target is 413 participants. The study started on 2021-03-19. Estimated completion is 2023-09-14.

What conditions does trial NCT04576065 study?

This clinical trial studies the following conditions: Critical Illness.

What interventions are being tested in trial NCT04576065?

The interventions under investigation include: WFIT (OTHER).

Who is sponsoring clinical trial NCT04576065?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04576065 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Critical Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04576065's enrollment target sits among peer trials

413 32nd of 91 higher than 60 of 91 other Critical Illness trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Critical Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03592472 · 413 participants · Phase 3

    A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)

  • NCT06697197 · 413 participants · Phase 1

    A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors

  • NCT04776941 · 414 participants · NA

    Expressive Writing for the Management of Stress in Cancer Survivors

  • NCT06792552 · 414 participants · Phase 1

    A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04576065, the US trial registry maintained by the National Library of Medicine. NCT04576065 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.